ANDA 202705, held by Sciegen Pharms. Fluocinolone Acetonide.
As of Nov 16, 2026, ANDA 202705 (Fluocinolone Acetonide), held by Sciegen Pharms, was first approved by FDA on Sep 9, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 9, 2016 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fluocinolone Acetonide0.01% ยท oil/drops;otic | Fluocinolone Acetonide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters